Home/Directory/Drug Discovery Services/Sygnature Discovery (Canada, formerly NuChem Sciences)

Sygnature Discovery (Canada, formerly NuChem Sciences)

Montreal, QC · Canada

Drug Discovery Serviceslarge

Specialization: Integrated discovery chemistry and biology CRO

Key Differentiator

Canadian arm of a UK discovery CRO with over 1,000 staff, built on the former NuChem Sciences sites.

Core Services

Medicinal and synthetic chemistry; Hit finding and compound management; Bioscience and in vivo pharmacology; Human disease modelling

Capabilities

Medicinal chemistryHigh throughput chemistryCompound managementIn vivo pharmacologyIntegrated drug discovery programs

Market Intelligence

UK-based Sygnature Discovery bought NuChem Sciences in 2023, adding 300+ staff in Montreal and Quebec City. Canadian sites are in Saint-Laurent (Montreal) and Saint-Romuald (Levis), and NuChem Sciences Inc. remains the registered Canadian entity.

Website

www.sygnaturediscovery.com

Similar Companies

Aragen Life Sciences (US)

Waltham, MA (US); Hyderabad, India (HQ) · Discovery chemistry & biology, DMPK

Growing discovery CRO

BioDuro-Sundia

Irvine, CA (HQ); San Diego, CA; China · Integrated discovery→manufacturing CRDMO

US-HQ CRDMO

Charles River Laboratories

Wilmington, MA (HQ); 150+ locations in 21 countries · GLP toxicology, safety assessment, ADME/DMPK

WORLD'S LARGEST preclinical CRO

Charles River Laboratories (Canada)

Senneville, QC; Sherbrooke, QC; Laval, QC · Drug discovery, safety assessment, DMPK, biologics testing, viral vector manufacturing

World's largest preclinical CRO — major Canadian operations across Quebec

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.